NEW YORK – Interpace Biosciences has experienced a busy year in both diagnostic development and biopharma services, including securing insurance coverage for multiple tests, a business acquisition, and a company rebranding to reflect the resulting expansion.
The Parsippany, New Jersey-based firm now aims to expand current relationships with multiple biopharmaceutical companies as it bolsters its service offerings for cancer therapeutics firms and, eventually, drug developers in other disease indications.